Seattle biotech Alpine Immune Sciences raises $91M for drug development By: Puget Sound Business Journal (Seattle) via Business Journals September 15, 2021 at 17:07 PM EDT The company, which went public in 2017, is developing drugs to help patients with autoimmune and inflammatory diseases. Read More >>